Previous 10 | Next 10 |
We recently wrote about options myths and a different way of trading. In this article, we break down myths around covered calls. These myths generally teach: (i) be out of the money; (ii) guess that the stock won't move much; and (iii) suffer losses if you're wrong. We explain...
4 Biotech Penny Stocks To Watch Heading Into March 2021 Like any good investor, the key to picking penny stocks to buy is a proper balance between speculation and research. While this applies heavily to biotech penny stocks, there are some additional factors to take into consideration. ...
Atossa Therapeutics ([[ATOS]] +12.6%) is rising today in morning hours after the company announced final results from its Phase 1 study for AT-301 nasal spray being developed for at home use for patients recently diagnosed with COVID-19.In the double-blinded, randomized, placebo-controlled cl...
SEATTLE, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases, with a current focus on breast...
We propose a method for selling options that defies many myths around options selling. We analyzed options prices using statistical modelling and calculus to improve the "expected value" of trading versus conventional principles. Trades based on the criteria below are likely to wi...
List Of Penny Stocks To Watch If Biotech Is Your Focus In Q1 When it comes to penny stocks , traders look for volatile sectors & industries. One of the more volatile sectors in the stock market today is biotechnology. Many different factors go into this. The main element is how ...
Atossa Therapeutics ([[ATOS]] -2.9%) said that it was in a strong position to continue the development of its clinical programs and opportunistically make accretive additions to the company's pipeline after navigating a year marred by the COVID-19 pandemic.The company's chief executive office...
SEATTLE, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical needs in oncology and infectious diseases, with a current focus on breas...
Nemaura Medical ([[NMRD]] +47.1%) and penny stocks, Zomedica ([[ZOM]] +14.1%), Senseonics Holdings ([[SENS]] +14.5%) are continuing their sharp premarket gains today.While no recent company-specific news can be attributed to the sudden interest, their short interest ranged from ~9.2% to ~19.3...
Today, we take our first in depth look at Atossa Therapeutics which is a small developmental concern based out of Seattle. The company's primary focus had been on the breast cancer space, but it pivoted somewhat in 2020 to the COVID-19 front. A full analysis is presented in the pa...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...